Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.
Hemotune has raised $15.6M in total funding. The most recent round was Series B. The last funding was announced in March 2024.
Hemotune's investors include Zúrcher Kantonal Bank, Venture Kick, Innosuisse, EASME, EIT Health.
Hemotune is headquartered in Schlieren, Switzerland.
Hemotune is a medical device company that develops a therapeutic blood purification platform for the treatment of health ailments.
Hemotune is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hemotune — Funding & Investors." VCBacked, March 25, 2024, https://www.vcbacked.co/company/hemotune. Accessed July 19, 2026.
VCBacked. (2024). Hemotune — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/hemotune
{{cite web |title=Hemotune — Funding & Investors |url=https://www.vcbacked.co/company/hemotune |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated